Atezolizumab Versus Chemotherapy in Advanced or Metastatic NSCLC with High Blood-Based Tumor Mutational Burden: Primary Analysis of BFAST Cohort C Randomized Phase 3 Trial.
Nature medicine（2022）
关键词
Non-small-cell lung cancer,Predictive markers,Biomedicine,general,Cancer Research,Metabolic Diseases,Infectious Diseases,Molecular Medicine,Neurosciences
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要